abstract |
An ophthalmic device comprising about a localized amount of an anti-allergic agent, in which the ophthalmic device is prepared from a formulation comprising etafilcon A and the anti-allergic agent is selected from the group consisting of cetotifen, its pharmaceutically acceptable salts and mixtures thereof, in which the localized amount refers to an amount of anti-allergic agent that is located in discrete parts of the ophthalmic device, and in which the localized amount of anti-allergic agent is between about 1 μg and about 200 μg. |